Swedish Orphan Biovitrum AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drug SEL-212, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).
/ 
Frequently asked questions
To buy Swedish Orphan Biovitrum AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Swedish Orphan Biovitrum AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Swedish Orphan Biovitrum AB is SOBIV:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Swedish Orphan Biovitrum AB has its primary listing on NASDAQ OMX Stockholm. You can trade Swedish Orphan Biovitrum AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Swedish Orphan Biovitrum AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Swedish Orphan Biovitrum AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Swedish Orphan Biovitrum AB.